Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Advisory - Two lots of the epilepsy drug Primidone recalled because of high levels of lead, which may pose serious health risks

Health Canada
Posted on: 07 Apr 18
Advisory - Two lots of the epilepsy drug Primidone recalled because of high levels of lead, which may pose serious health risks

Canada NewsWire

OTTAWA, April 6, 2018

OTTAWA, April 6, 2018 /CNW/ -

Health Canada is advising Canadians that AA Pharma Inc. is voluntarily recalling two lots of Primidone tablets because they contain high levels of lead. The company has indicated that only the lots identified below are affected by this issue.

Primidone is a prescription anti-epileptic drug used to control seizures. Lead is a heavy metal and can pose serious health risks when too much is ingested, particularly by children, and pregnant and breastfeeding women.

Who is affected

  • Consumers who have bought or used the affected product

Affected product






Lot Number



125 mg


100 tablets




250 mg


100 tablets




What consumers should do

  • Return the product to your pharmacy for replacement as soon as possible if you have product from the affected lots.
  • Do not stop taking Primidone without talking to your doctor. Stopping Primidone suddenly can cause serious problems, including seizures that may not stop.
  • Consult with your health care professional if you have taken these tablets and have health concerns.
  • Contact AA Pharma Inc. via Stericycle by calling 1-888-228-5053 or by email at if you have questions about this recall.
  • Report adverse events to health products to Health Canada by calling toll-free at 1‑866‑234‑2345, or by reporting online, by mail or by fax.
  • Report complaints about health products to Health Canada by calling toll-free at 1‑800‑267‑9675, or complete an online complaint form.

Additional information for pharmacies:

  • Retail and hospital pharmacies that have dispensed these products are being asked by the company to contact individuals who have received the impacted lots and to recover units from the impacted lot for return. The company has sent a notice to wholesalers and distributors to communicate the recall and advise on what to do.
  • Pharmacies may contact AA Pharma Inc. via Stericycle at 1-888-228-5053 for further information on the recall.

What Health Canada is doing
Health Canada is monitoring the company's recall. Should additional safety information be identified, Health Canada will take appropriate action and inform Canadians.

Lead consumed in excessive amounts poses serious health risks because it may accumulate in vital organs of the body. Toxic effects include miscarriage and other reproductive effects, kidney and brain damage, abdominal pain, anemia, loss of appetite, constipation, fatigue, sleeplessness, irritability, headache, changes in blood pressure, weakness, concentration problems, weight loss, and dizziness. Children, and pregnant and breastfeeding women are the most susceptible to the toxic effects.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français


SOURCE Health Canada

PR Newswire

Last updated on: 07/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.